VAERS reports by lot

Pfizer COVID-19 lot ER8739: VAERS reports

22 VAERS reports list lot ER8739 as a Pfizer COVID-19 vaccine, received between 2021-03-25 and 2021-12-27. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
22
Reports
9%
Marked serious
1
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1522%
Neurological1319%
Gastrointestinal1218%
Cardiac / Cardiovascular812%
Musculoskeletal69%
Injection-site / Local reaction46%
Respiratory34%
Allergic / Anaphylactic23%
Reproductive / Menstrual23%
Dermatological (non-injection-site)11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California5
Connecticut2
Arizona2
Colorado2
Tennessee2
Illinois1
West Virginia1
Oklahoma1
Florida1
South Carolina1
Virginia1
New York1

Reports by month received

2021-033
2021-045
2021-052
2021-061
2021-072
2021-081
2021-091
2021-106
2021-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.